Baidu
map

Arthritis Rheumatol:痛风中的病因特异性死亡率

2019-06-10 xiangting MedSci原创

痛风患者中一些非CV病因的死亡率升高,这突出了改善合并症治疗的需要。

这项研究旨在探讨与一般人群相比,痛风患者除心血管(CV)疾病以外的病因特异性死亡率。

纳入2002年Sk?ne(瑞典)18岁以上的所有居民,研究人员使用Sk?ne医疗登记,确定了新诊断的痛风患者(2003-2013),并根据年龄和性别将1个痛风患者与10个无痛风的对照进行匹配。使用来自死因登记(截至2014 年12月31 日)的死因信息,在多状态Cox模型中调整潜在混杂因素后,估算了特定死因的死亡率风险比(HR)。

在832,258人中,有19,497人新诊断为痛风(32%为女性),并与194,947名对照者进行匹配。痛风患者慢性肾病、代谢和CV合并症的患病率较高。总体上,痛风与全因死亡率(HR 1.17,95%可信区间1.14-1.21)升高17%相关,女性升高23%(HR 1.23,1.17-1.30),男性升高15%(HR 1.15,1.10-1.19)。就病因特异性死亡率而言,痛风与肾病(HR 1.78,1.34-2.35)、消化系统疾病(HR 1.56,1.34-1.83)、CV疾病(HR 1.27,1.22-1.33)、感染(HR 1.20,1.06-1.35)、痴呆(HR 0.83,0.72-0.97)导致死亡风险的相关性最强。

痛风患者中一些非CV病因的死亡率升高,这突出了改善合并症治疗的需要。

原始出处:

Ana Beatriz Vargas‐Santos. Cause‐Specific Mortality in Gout: Novel Findings of Elevated Risk of Non‐Cardiovascular Related Deaths. Arthritis Rheumatol. 06 June 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Jan 08 13:30:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799520, encodeId=7a701e99520fb, content=<a href='/topic/show?id=b8d7e08467a' target=_blank style='color:#2F92EE;'>#病因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70846, encryptionId=b8d7e08467a, topicName=病因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Tue Mar 10 20:30:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972651, encodeId=473519e265139, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Aug 30 09:30:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994602, encodeId=aa631994602ce, content=<a href='/topic/show?id=5135e08474e' target=_blank style='color:#2F92EE;'>#病因特异性死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70847, encryptionId=5135e08474e, topicName=病因特异性死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Wed Mar 04 03:30:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357207, encodeId=cda6135e207a1, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 12 03:30:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Jan 08 13:30:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799520, encodeId=7a701e99520fb, content=<a href='/topic/show?id=b8d7e08467a' target=_blank style='color:#2F92EE;'>#病因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70846, encryptionId=b8d7e08467a, topicName=病因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Tue Mar 10 20:30:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972651, encodeId=473519e265139, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Aug 30 09:30:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994602, encodeId=aa631994602ce, content=<a href='/topic/show?id=5135e08474e' target=_blank style='color:#2F92EE;'>#病因特异性死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70847, encryptionId=5135e08474e, topicName=病因特异性死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Wed Mar 04 03:30:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357207, encodeId=cda6135e207a1, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 12 03:30:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Jan 08 13:30:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799520, encodeId=7a701e99520fb, content=<a href='/topic/show?id=b8d7e08467a' target=_blank style='color:#2F92EE;'>#病因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70846, encryptionId=b8d7e08467a, topicName=病因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Tue Mar 10 20:30:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972651, encodeId=473519e265139, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Aug 30 09:30:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994602, encodeId=aa631994602ce, content=<a href='/topic/show?id=5135e08474e' target=_blank style='color:#2F92EE;'>#病因特异性死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70847, encryptionId=5135e08474e, topicName=病因特异性死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Wed Mar 04 03:30:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357207, encodeId=cda6135e207a1, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 12 03:30:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Jan 08 13:30:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799520, encodeId=7a701e99520fb, content=<a href='/topic/show?id=b8d7e08467a' target=_blank style='color:#2F92EE;'>#病因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70846, encryptionId=b8d7e08467a, topicName=病因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Tue Mar 10 20:30:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972651, encodeId=473519e265139, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Aug 30 09:30:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994602, encodeId=aa631994602ce, content=<a href='/topic/show?id=5135e08474e' target=_blank style='color:#2F92EE;'>#病因特异性死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70847, encryptionId=5135e08474e, topicName=病因特异性死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Wed Mar 04 03:30:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357207, encodeId=cda6135e207a1, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 12 03:30:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1899296, encodeId=f2461899296f5, content=<a href='/topic/show?id=6f746e94170' target=_blank style='color:#2F92EE;'>#特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67941, encryptionId=6f746e94170, topicName=特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc7a157, createdName=jinweidong, createdTime=Wed Jan 08 13:30:00 CST 2020, time=2020-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1799520, encodeId=7a701e99520fb, content=<a href='/topic/show?id=b8d7e08467a' target=_blank style='color:#2F92EE;'>#病因特异性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70846, encryptionId=b8d7e08467a, topicName=病因特异性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfab443, createdName=saikp, createdTime=Tue Mar 10 20:30:00 CST 2020, time=2020-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1972651, encodeId=473519e265139, content=<a href='/topic/show?id=8a6a2e8839' target=_blank style='color:#2F92EE;'>#Arthritis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2788, encryptionId=8a6a2e8839, topicName=Arthritis)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIibticIBly5jCSic5ZElW4He3rO4DMpUHUFaFX57OicNMnzckWaicBNeStwugWHFCuOdicoakApM4HGmtw/132, createdBy=f8672500006, createdName=ms6390871039024434, createdTime=Fri Aug 30 09:30:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994602, encodeId=aa631994602ce, content=<a href='/topic/show?id=5135e08474e' target=_blank style='color:#2F92EE;'>#病因特异性死亡率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70847, encryptionId=5135e08474e, topicName=病因特异性死亡率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8ba7103, createdName=xuqianhua, createdTime=Wed Mar 04 03:30:00 CST 2020, time=2020-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1357207, encodeId=cda6135e207a1, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Wed Jun 12 03:30:00 CST 2019, time=2019-06-12, status=1, ipAttribution=)]
    2019-06-12 zhaojie88

相关资讯

Arthritis Rheumatol:别嘌呤醇剂量增加对痛风骨侵蚀和尿酸盐体积的影响

这项研究目的是探讨痛风患者中,为了达到血清尿酸盐目标的别嘌呤醇剂量增加是否会影响通过DECT测量的骨侵蚀或尿酸单钠(MSU)晶体沉积。研究人员对一个为期两年的随机临床试验进行了成像研究,该试验在使用别嘌呤醇且SU≥0.36mmol/L的痛风患者中,比较了别嘌呤醇剂量直接增至血清尿酸盐(SU)目标vs.常规剂量1年,随后剂量增至目标(对照)。在基线、1年和2年随诊时获取足部DECT扫描和X光片(XR

痛风急性发作时的药物治疗

痛风是尿酸盐晶体沉积所致的一种炎症性疾病,绝大多数痛风发生在第一跖趾关节。夏天吹空调、冬天保暖差、大量饮酒、暴饮暴食,是诱发痛风发作的常见因素。痛风急性发作期治疗目的是迅速控制关节炎症状,非甾体抗炎药、秋水仙碱和糖皮质激素是常用药物。这三类药物之间有何区别,临床应如何选择?

痛风急性期,药怎么吃?

随着社会经济发展,人们生活方式及饮食结构改变,我国高尿酸血症的患病率逐年增高,并呈年轻化趋势,已成为仅次于糖尿病的第二大代谢性疾病。血尿酸升高除可引起痛风之外,还与肾脏、内分泌代谢、心脑血管等系统疾病的发生和发展有关。所以了解痛风,并控制疾病的发生发展显得尤为重要。

痛风的受累人群已高达1.2亿 三大治疗方法需掌握

当今,一个危险的健康杀手正悄悄在人群中蔓延。它隐藏在冰啤、海鲜等高嘌呤食物中,也躲避在人们的不良生活习惯里。目前,受累的人群已高达1.2亿。它就是痛风的罪魁祸首,高尿酸血症。高尿酸应该这么定义!正常人的血尿酸值男性约为3.5-7.0mg/dl,女性约为2.5-6.0mg/dl。由于绝经后雌激素水平下降,女性的血尿酸值在绝经期后接近男性。鉴于性别差异,指南与教科书常将高尿酸血症进行分开定义,将男

痛风致腕关节破坏误诊为肿瘤1例

患者,男,48岁。因“右腕部包块5年”就诊。期间间断性疼痛发作,肿胀,行抗炎注射治疗,症状消失。于2017年4月28日再次发作,经抗炎治疗无好转。体检:右腕部尺侧有一4CM×4CM×3CM包块,质硬,局部皮肤发红,温度较正常高,皮肤无破溃,不可推动,腕关节屈伸及旋转活动疼痛受限。患者否认痛风、结核及其他关节疼痛病史。X线片及CT显示腕关节尺骨远端骨质破坏(图1A);MRI显示右尺骨远端及周围软组织

治疗痛风发作要不要用激素?什么情况下使用?副作用如何?

治疗痛风急性发作,有三类药物可以选择:秋水仙碱、非甾体类消炎药(解热止痛药)和激素。其中,前两类是一线药物,应该首选。

Baidu
map
Baidu
map
Baidu
map